Author

O. Zlotnik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Gutwillig· 1 shared A. Kapelanski-Lamoureux· 1 shared A. Lazaris· 1 shared A. Madi· 1 shared C. Luxenburg· 1 shared D. Rasoulouniriana· 1 shared G. Shapira· 1 shared J. Cohen· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Gutwillig

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 24, 2022

Disruption of integrin alpha-5/beta-1-dependent transforming growth factor beta-1signaling pathway attenuates vessel co-option in colorectal cancer liver metastases

M. Rada, A. Kapelanski-Lamoureux, O. Zlotnik…·P. Metrakos

This study shows that inhibiting the integrin alpha-5/beta-1 pathway reduces vessel co-option in colorectal cancer liver metastases by suppressing TGFβ1-driven Ang1 expression.

DOI 10.1101/2022.05.24.493291

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 10, 2020

Transient cell-in-cell formation underlies tumor resistance to immunotherapy

A. Gutwillig, N. Santana-Magal, L. Farhat-Younis…·Y. Carmi

This study identifies transient cell-in-cell formations as a mechanism enabling tumor resistance to immunotherapy, showing they protect tumor cells from immune and chemotherapy attacks.

DOI 10.1101/2020.09.10.287441

mousewhole-exome sequencing

𝕏 PostBluesky